From Vanilla Zone to Catalyst: Paul Simms on Rebuilding Pharma
What happens when an entire industry built on “playing it safe” is asked to imagine it’s been wiped out by a meteor and must start again from scratch?
In this episode of The Reflective Professional, Chris Cahill sits down with Paul Simms, founder of Impatient Health and creator of Pharmageddon, to explore how pharma can move beyond incrementalism, fear, and compliance culture to become truly bold and patient‑centric.
Paul shares why he believes much of pharma has become “vision‑less,” how legal and regulatory pressures push teams into the “vanilla zone,” and what it takes to shift from being a distributor of status quo ideas to a catalyst for meaningful change. Chris and Paul unpack why most “pilots” are only run when success is almost guaranteed, how early adopters get stranded when they return to business‑as‑usual, and why curiosity, experimentation, and psychological safety are non‑negotiable for genuine innovation.
If you work in pharma, healthcare, or any highly regulated industry and feel stuck between big aspirations and small, safe moves, this conversation will resonate. You’ll hear practical ideas on building braver cultures, measuring “softer” impact, and creating communities—like the Pharmageddon pods—that hold each other accountable for actually doing things differently once the conference buzz fades.
Tune in if you’re ready to question your own risk appetite, reconsider how you use pilots and KPIs, and rediscover what it means to be a catalyst rather than just a cog.
Connect with Paul Simms:
